Literature DB >> 1409194

Falciparum malaria-induced hypoglycaemia in a diabetic patient.

O Shalev1, A Tsur, G Rahav.   

Abstract

We report a patient with diabetes mellitus who suffered severe falciparum malaria complicated by profound and persistent hypoglycaemia. The hypoglycaemia evolved before therapy with quinine was begun and resolved with eradication of the parasitaemia. The patient reverted to her baseline hyperglycaemia despite continuation of quinine. This case illustrates the critical role of falciparum malaria in the pathogenesis of malaria-associated hypoglycaemia, rather than quinine-mediated mechanisms. Anticipation of hypoglycaemia in falciparum malaria and its vigorous treatment may improve the poor prognosis associated with this complication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409194      PMCID: PMC2399263          DOI: 10.1136/pgmj.68.798.281

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

Review 1.  Hypoglycaemia is an important complication of falciparum malaria.

Authors:  R E Phillips
Journal:  Q J Med       Date:  1989-06

2.  Severe symptomatic hypoglycaemia due to quinine therapy.

Authors:  R G Jones; H M Sue-Ling; C Kear; P G Wiles; P Quirke
Journal:  J R Soc Med       Date:  1986-07       Impact factor: 5.344

3.  Hypoglycaemia in African children with severe malaria.

Authors:  N J White; K D Miller; K Marsh; C D Berry; R C Turner; D H Williamson; J Brown
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

4.  High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria.

Authors:  W Okitolonda; C Delacollette; M Malengreau; J C Henquin
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-19

5.  Malarial parasite hexokinase and hexokinase-dependent glutathione reduction in the Plasmodium falciparum-infected human erythrocyte.

Authors:  E F Roth
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

6.  Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria.

Authors:  T E Taylor; M E Molyneux; J J Wirima; K A Fletcher; K Morris
Journal:  N Engl J Med       Date:  1988-10-20       Impact factor: 91.245

7.  Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria.

Authors:  M E Molyneux; S Looareesuwan; I S Menzies; S L Grainger; R E Phillips; Y Wattanagoon; R P Thompson; D A Warrell
Journal:  Am J Trop Med Hyg       Date:  1989-05       Impact factor: 2.345

8.  Severe hypoglycemia and hyperinsulinemia in falciparum malaria.

Authors:  N J White; D A Warrell; P Chanthavanich; S Looareesuwan; M J Warrell; S Krishna; D H Williamson; R C Turner
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

9.  Specificity of hypoglycaemia for cerebral malaria in children.

Authors:  N G Kawo; A E Msengi; A B Swai; L M Chuwa; K G Alberti; D G McLarty
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

  9 in total
  5 in total

1.  Falciparum malaria and hypoglycaemia.

Authors:  M Odeh
Journal:  Postgrad Med J       Date:  1993-04       Impact factor: 2.401

2.  Blood-stage malaria infection in diabetic mice.

Authors:  K Elased; J B De Souza; J H Playfair
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

3.  Malaria and obesity: obese mice are resistant to cerebral malaria.

Authors:  Vincent Robert; Catherine Bourgouin; Delphine Depoix; Catherine Thouvenot; Marie-Noëlle Lombard; Philippe Grellier
Journal:  Malar J       Date:  2008-05-19       Impact factor: 2.979

4.  Illness experiences of diabetes in the context of malaria in settings experiencing double burden of disease in southeastern Tanzania.

Authors:  Emmy Metta; Ajay Bailey; Flora Kessy; Eveline Geubbels; Hinke Haisma
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

5.  Seasonality in diabetes in Yaounde, Cameroon: a relation with precipitation and temperature.

Authors:  Eric Lontchi-Yimagou; Maurice Tsalefac; Leonelle Monique Teuwa Tapinmene; Jean Jacques N Noubiap; Eric Vounsia Balti; Jean-Louis Nguewa; Mesmin Dehayem; Eugene Sobngwi
Journal:  BMC Public Health       Date:  2016-06-06       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.